489 related articles for article (PubMed ID: 19340897)
1. Clostridium difficile associated infection, diarrhea and colitis.
Hookman P; Barkin JS
World J Gastroenterol; 2009 Apr; 15(13):1554-80. PubMed ID: 19340897
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection: clinical spectrum and approach to management.
Vaishnavi C
Indian J Gastroenterol; 2011 Dec; 30(6):245-54. PubMed ID: 22183580
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile-associated diarrhea and colitis.
Gerding DN; Johnson S; Peterson LR; Mulligan ME; Silva J
Infect Control Hosp Epidemiol; 1995 Aug; 16(8):459-77. PubMed ID: 7594392
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile and the disease it causes.
Norén T
Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.
Walbrown MA; Aspinall SL; Bayliss NK; Stone RA; Cunningham F; Squier CL; Good CB
J Manag Care Pharm; 2008; 14(1):34-40. PubMed ID: 18240880
[TBL] [Abstract][Full Text] [Related]
7. NAP1 strain type predicts outcomes from Clostridium difficile infection.
See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
[TBL] [Abstract][Full Text] [Related]
8. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
[TBL] [Abstract][Full Text] [Related]
9. Bench-to-bedside review: Clostridium difficile colitis.
Gould CV; McDonald LC
Crit Care; 2008; 12(1):203. PubMed ID: 18279531
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease.
Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022
[TBL] [Abstract][Full Text] [Related]
11. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence.
Deshpande A; Pant C; Jain A; Fraser TG; Rolston DD
Curr Med Res Opin; 2008 Feb; 24(2):329-33. PubMed ID: 18067688
[TBL] [Abstract][Full Text] [Related]
12. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.
Jen MH; Saxena S; Bottle A; Aylin P; Pollok RC
Aliment Pharmacol Ther; 2011 Jun; 33(12):1322-31. PubMed ID: 21517920
[TBL] [Abstract][Full Text] [Related]
13. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
[TBL] [Abstract][Full Text] [Related]
14. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
Lamont JT
Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Clostridium difficile-associated disease in North America and Europe.
Kuijper EJ; Coignard B; Tüll P; ; ;
Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
[TBL] [Abstract][Full Text] [Related]
16. Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
Zhou F; Hamza T; Fleur AS; Zhang Y; Yu H; Chen K; Heath JE; Chen Y; Huang H; Feng H
Inflamm Bowel Dis; 2018 Feb; 24(3):573-582. PubMed ID: 29462386
[TBL] [Abstract][Full Text] [Related]
17. An epidemic, toxin gene-variant strain of Clostridium difficile.
McDonald LC; Killgore GE; Thompson A; Owens RC; Kazakova SV; Sambol SP; Johnson S; Gerding DN
N Engl J Med; 2005 Dec; 353(23):2433-41. PubMed ID: 16322603
[TBL] [Abstract][Full Text] [Related]
18. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile.
Kyne L; Merry C; O'Connell B; Kelly A; Keane C; O'Neill D
Age Ageing; 1999 Mar; 28(2):107-13. PubMed ID: 10350405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
